Latest News in the pharma Industry

All

Acerus receives Notice of Deficiency from Health Canada for Gynoflor

Acerus receives Notice of Deficiency from Health Canada for Gynoflor

27 Dec 2017

Health Canada requests additional technical information on Gynoflor to complete its assessment of the product.

Read more 
FiH trial of new immunotherapy approach shows efficacy in antibiotic resistance

FiH trial of new immunotherapy approach shows efficacy in antibiotic resistance

27 Dec 2017

Human polyclonal antibodies show promise as effective treatment.

Read more 
Crown Bioscience and JSR Corporation to merge

Crown Bioscience and JSR Corporation to merge

21 Dec 2017

Merger integrates Crown Bioscience’s leading translational technology platform providing drug target validation, efficacy testing and patient response characterization with JSR’s IVD solutions, GMP manufacturing capabilities and worldwide distribution ...

Read more 
Biogen and Ionis collaborate to identify novel therapies for the treatment of SMA

Biogen and Ionis collaborate to identify novel therapies for the treatment of SMA

21 Dec 2017

New collaboration agreement to identify new antisense oligonucleotide drug candidates.

Read more 
FDA clears myPKFiT for ADVATE to help personalize care for hemophilia A

FDA clears myPKFiT for ADVATE to help personalize care for hemophilia A

19 Dec 2017

First and only FDA-cleared PK dosing software to support healthcare professionals in creating personalized dosing regimens for patients 16 and older with hemophilia A.

Read more 
Collaboration to develop innovative technologies

Collaboration to develop innovative technologies

20 Dec 2017

Project will innovate technologies in epigenetic characterisation for patient stratification in renowned precision medicine.

Read more 
NIH study uncovers clues about why common cancer drug causes hearing loss

NIH study uncovers clues about why common cancer drug causes hearing loss

20 Dec 2017

Researchers find target to protect hearing during chemotherapy treatment.

Read more 
Impax sells Taiwan manufacturing facility

Impax sells Taiwan manufacturing facility

20 Dec 2017

Bora Pharmaceuticals to pay purchase price of $18.5 million and will have the rights to market and sell Impax's branded Parkinson's drug Rytary (Numient outside the US) in Taiwan.

Read more 
Major changes for bio supply forecast in 2018 by bioLIVE

Major changes for bio supply forecast in 2018 by bioLIVE

19 Dec 2017

Integration of supply chain a critical issue as industry globalises, with a resurgence in European manufacturing and biotech markets forecast.

Read more 
Hikma signs licensing agreement with Celltrion for third biosimilar product in MENA region

Hikma signs licensing agreement with Celltrion for third biosimilar product in MENA region

19 Dec 2017

Truxima is mAb biosimilar to Roche's MabThera (rituximab).

Read more 
Regeneron and ISA Pharma to advance immuno-oncology treatment

Regeneron and ISA Pharma to advance immuno-oncology treatment

18 Dec 2017

Collaboration to conduct clinical trials of the combination treatment in both cervical and head-and-neck cancer.

Read more 
Teva to axe 25% of its total workforce

Teva to axe 25% of its total workforce

18 Dec 2017

Total cost base to be reduced by $3 billion by the end of 2019.

Read more